New Key Statistics Module, Z-Score and F-Score
NAS:EYPT Key Ratios
| Market Cap $ M | 629.70 |
| Enterprise Value $ M | 334.97 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.23 |
| Price/Sales | 10.29 |
| Price/Free Cash Flow | 335.83 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 46.00 |
| EPS (TTM) $ | -1.82 |
| Beneish M-Score | -3.71 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 27.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.82 |
| EV-to-EBITDA | -4.85 |
| PEG | -- |
| Shares Outstanding M | 52.08 |
| Net Margin (%) | -153.84 |
| Operating Margin % | -163.13 |
| Pre-tax Margin (%) | -153.66 |
| Quick Ratio | 5.39 |
| Current Ratio | 5.45 |
| ROA % (ttm) | -34.51 |
| ROE % (ttm) | -63.55 |
| ROIC % (ttm) | -200.03 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.76 |
EYPT Number of Guru Trades
EYPT Volume of Guru Trades
Gurus Latest Trades with NAS:EYPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:EYPT is held by these investors
Total 1
EyePoint Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:EYPT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers